The sustained anti-tumor effect of CD8+ T cells after drug withdrawal was likely related to the formation of TLS, as indicated by a large number of BrdU+ CD8+ T cells were present in TLS and a positive correlation between TLS score and CD8A expression in BAY1082439-treated TEN-null prostate cancer (93). The gene discussed is CD8A; the disease is prostate carcinoma.